Oral Semaglutide Improves liver steatosis and injury in Diabetes Patients with MASLD, suggests study Jacinthlyn Sylvia29 Oct 2024 8:45 AM ISTA recent study highlights the potential benefits of oral semaglutide in managing type 2 diabetes mellitus (T2DM) for patients with metabolic...
Lowering Risk of Alzheimer's in Diabetes Patients? Semaglutide May Help, Study Suggests Dr. Bhumika Maikhuri29 Oct 2024 8:00 AM ISTResearchers at the Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular...
SGLT2 inhibitor canagliflozin has Heart and kidney benefits among patients across all age categories: Study Dr Kartikeya Kohli28 Oct 2024 8:30 PM ISTSodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is...
Vericiguat Lowers Cardiovascular Death Risk in Heart Failure Patients, Independent of Diabetes: VICTORIA Trial Analysis Medha Baranwal24 Oct 2024 9:00 AM ISTUSA: The recent analysis from the VICTORIA trial has highlighted the potential benefits of vericiguat in managing cardiovascular (CV) outcomes for...
Higher Satisfaction with Once-Weekly Insulin Icodec Compared to Daily Doses in Type 2 Diabetes: ONWARDS Trials Medha Baranwal24 Oct 2024 9:00 AM ISTUSA: A recent analysis from the ONWARDS clinical trials has revealed significant improvements in treatment satisfaction among individuals with Type 2...
Novo Nordisk's oral Semaglutide cuts cardiovascular risks by 14 percent, study finds MD Bureau23 Oct 2024 3:29 PM ISTNovo expects to file for a label expansion for Rybelsus in the United States and the European Union around the turn of the year.
Medical Bulletin 23/ October/ 2024 Dr. Bhumika Maikhuri23 Oct 2024 3:00 PM ISTHere are the top medical news for the day:New guideline by ASA: Preventing a first stroke may be possible with screening, lifestyle changesThe "2024...
Melatonin Supplementation Improves Glycemic Control in Type 2 Diabetes, Research Finds Medha Baranwal23 Oct 2024 8:45 AM ISTIran: A recent systematic review and meta-analysis have highlighted the potential benefits of melatonin supplementation for individuals with Type 2...
SOUL Trial Shows 14% Reduction in Cardiovascular Events with Oral Semaglutide in Type 2 Diabetes Dr. Bhumika Maikhuri23 Oct 2024 8:15 AM ISTThe SOUL cardiovascular outcomes trial was a double-blinded, randomised trial that compared oral semaglutide to placebo as an adjunct to standard of...
Oral semaglutide cuts MACE risk by 14% in adults with type 2 diabetes: SOUL trial Dr. Kamal Kant Kohli22 Oct 2024 9:30 AM ISTAccording to new data from the SOUL trial Oral semaglutide reduced MACE by 14% in Type 2 Diabetes patients. Novo Nordisk will present more detailed...
Study Reveals No Impact of Normal Vitamin B12 Levels on Diabetic Foot Ulcer Development Dr Riya Dave18 Oct 2024 9:00 AM ISTResearchers have reported that diabetic foot ulcer (DFU) is one of the major complications of diabetes, normal vitamin B12 levels seem to offer no...
Review Explores Impact of GLP-1 Agonists on Type 2 Diabetes and Weight Management Medha Baranwal16 Oct 2024 8:45 AM ISTUSA: A recent narrative review has highlighted the effectiveness of GLP-1 receptor agonists (RAs) in treating type 2 diabetes and obesity. These...
